Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases.

Dario Baratti, Paolo Sammartino, Shigeki Kusamura, Marcello Deraco, Peritoneal Surface Malignancy Onco-team of the Italian Society of Surgical Oncology (SICO), Luca Ansaloni, Salvatore Asero, Gianluca Baiocchi, Pietro Bagnoli, Davide Cavaliere, Massimo Framarini, Roberto Cirocchi, Federico Coccolini, Franco Decian, Paolo Delrio, Cinzia Sassaroli, Michele De Simone, Manuela Robella, Marco Vaira, Andrea Di GiorgioAnna Fagotti, Domenica Lorusso, Orietta Federici, Giammaria Fiorentini, Massimiliano Fambrini, Stefano Scaringi, Alfredo Garofalo, Mario Valle, Roberta Gelmini, Francesca Cabry, Nicola Cautero, Lorena Sorrentino, Luigina Graziosi, Marcello Guaglio, Matteo Montenovo, Valentina Bartolini, Piero Vincenzo Lippolis, Antonio Macrì, Enrico Maria Pasqual, Francesco Roviello, Daniele Marrelli, Elena Orsenigo, Antonio Sommariva

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)737-739
Number of pages3
JournalEuropean Journal of Surgical Oncology
Volume46
DOIs
Publication statusPublished - May 1 2020

Keywords

  • Acute Kidney Injury
  • epidemiology
  • Anastomotic Leak
  • Antineoplastic Combined Chemotherapy Protocols
  • administration & dosage
  • Chemotherapy
  • Adjuvant
  • methods
  • Cisplatin
  • Colorectal Neoplasms
  • pathology
  • therapy
  • Digestive System Surgical Procedures
  • Humans
  • Hyperthermic Intraperitoneal Chemotherapy
  • Mitomycin
  • Oxaliplatin
  • Pancreatitis
  • Peritoneal Neoplasms
  • drug therapy
  • prevention & control
  • secondary
  • Postoperative Complications

Cite this